<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04016740</url>
  </required_header>
  <id_info>
    <org_study_id>2019P000407</org_study_id>
    <nct_id>NCT04016740</nct_id>
  </id_info>
  <brief_title>The PATHFINDER Study: A Feasibility Trial</brief_title>
  <acronym>PATHFINDER</acronym>
  <official_title>Perioperative Multimodal General Anesthesia Focusing on Specific CNS Targets in Patients Undergoing Cardiac Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to determine whether a rational strategy of EEG guided
      multimodal general anesthesia using target specific sedative and analgesics could result in
      enhanced recovery after anesthesia and surgery, decrease in postoperative delirium, and
      decrease in long term postoperative cognitive dysfunction up to 6 months following cardiac
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main purpose of this study is to determine whether a rational strategy of EEG guided
      multimodal general anesthesia using target specific sedative and analgesics could result in
      enhanced recovery after anesthesia and surgery, decrease in postoperative delirium, and
      decrease in long term postoperative cognitive dysfunction up to 6 months following cardiac
      surgery.

      Specific Aim 1: The feasibility of implementing multimodal general anesthesia strategy in the
      Operating Rooms (OR) Specific Aim 2: The feasibility of implementing EEG guided sedation
      until extubation in the Intensive Care Unit (ICU) Specific Aim 3: The enhancement of recovery
      after surgery (shorter ventilation time, ICU stay, hospital length of stay) Specific Aim 4:
      To estimate the effect size of decrease in postoperative day (POD) and postoperative
      cognitive dysfunction (POCD) to power future large randomized trials
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 20, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>2 roll-in patients followed by 20 patients in the interventional model.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Delirium</measure>
    <time_frame>Participants will be followed for the duration of the hospital stay, an average of 5 days</time_frame>
    <description>Incidence of delirium will be analyzed in patients treated with the multi-modal approach. Delirium will be defined as an acute change in pre-operative baseline condition with additional features of inattention and either disorganized thinking and altered loss of consciousness, as defined by the Confusion Assessment Method (CAM)Assessment Method (CAM) algorithm postoperatively until discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>Time of ICU admission until time of extubation in ICU, an average of 6 hours</time_frame>
    <description>Time to extubation will be noted from ICU data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Montreal Cognitive Assessment (MoCA)</measure>
    <time_frame>On the day of discharge, an average of 6 days</time_frame>
    <description>MoCA scores (total possible score is 30 points; a score of 26 or above is considered normal) at discharge will be reported in order to assess the occurrence of postoperative cognitive decline. Study staff trained in administering the assessments will collect the data.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores</measure>
    <time_frame>At 4-8 hourly intervals every day until discharge, an average of 6 days</time_frame>
    <description>Patient reported pain scores on a scale from 0-10 (0 no pain,10 extreme pain), until discharge for the index admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioid and supplemental analgesic consumption</measure>
    <time_frame>48 hours, post-operative</time_frame>
    <description>The total opioid dosage and supplemental analgesic dosage received in the first 48 hours postoperatively will be abstracted from the medical record.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU</measure>
    <time_frame>Time of ICU admission until time of discharge to hospital floor; through the hospital stay, an average of 5 days</time_frame>
    <description>Total duration of stay in ICU for the index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU/hospital length of stay</measure>
    <time_frame>Time of stay in the hospital until discharge to floor or rehab, an average of 5 days</time_frame>
    <description>Their stay in the hospital for the index admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital complications</measure>
    <time_frame>7 days post-op on an average</time_frame>
    <description>stroke, myocardial infarction (MI), acute kidney injury, pneumonia, reintubation, congestive heart failure, sepsis, reopening of sternum and all-cause mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow up incidence of delirium</measure>
    <time_frame>Patients will be assessed for delirium at 1 month and 6 months following the date of surgery</time_frame>
    <description>The follow up incidence of delirium will be analyzed at 1 month and 6 months after discharge. Delirium will be defined as an acute change in pre-operative baseline condition with additional features of inattention and either disorganized thinking and altered loss of consciousness, as defined by the MoCA/t-MoCA.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative
The anesthesiologists involved in this study will be trained to infer differences in anti-nociception, unconsciousness movement and changes during other perioperative events by monitoring EEG. They will also be trained in titrating hypnotic and nociceptic medications based on changes in EEG.
Routine anesthetic induction
Bilateral Pectoro-interfascial block (PIFB) with 20 mL of 0.25% ropivacaine on either side of the sternum after anesthetic induction but before surgical incision
Ketamine (0.06 to 0.12 mg.kg/hr)
Remifentanil (0.05-0.2 mcg/kg/min)
Dexmedetomidine (0.2-1.0 mcg/kg/hr)
Rocuronium intermittent bolus (TOF)
Propofol infusion Â± Sevoflurane titrated based on EEG monitoring
Postoperative
Standard pain management protocol
Dexmedetomidine infusion 0.2-1.4 mcg/kg/hr (EEG guided)
Infusion continued till extubation
Propofol infusion may be added/used for sedation based on the treating physician's discretion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Practice with EEG monitoring</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The initial 2 patients will receive standard anesthesia practice and perioperative EEG monitoring will be recorded to learn the patterns associated with our standard practice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Intraoperative bilateral PIFB block with 20 mL of 0.25% Ropivicaine on either side of the sternum after anesthetic induction but before surgical incision</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Intraoperative infusion</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>Intraoperative infusion</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Intraoperative infusion</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>Intraoperative intermittent bolus</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Intraoperative infusion</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Intraoperative inhaled as needed</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Post-operative infusion</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Post-operative infusion</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG monitoring</intervention_name>
    <description>Perioperative monitoring</description>
    <arm_group_label>Multimodal General Anesthesia</arm_group_label>
    <arm_group_label>Standard Practice with EEG monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age â¥ 60 years

          2. Undergoing any of the following types of surgery with cardiopulmonary bypass limited
             to coronary artery bypass surgery (CABG), CABG+valve surgeries and isolated valve
             surgeries.

        Exclusion Criteria:

          1. Preoperative left ventricular ejection fraction (LVEF) &lt;30%

          2. Emergent surgery

          3. Non-English speaking

          4. Cognitive impairment as defined by total MoCA score &lt; 10

          5. Currently enrolled in another interventional study that could impact the primary
             outcome, as determined by the PI

          6. Significant visual impairment

          7. Chronic opioid use for chronic pain conditions with tolerance (total dose of an opioid
             at or more than 30 mg morphine equivalent for more than one month within the past
             year)

          8. Hypersensitivity to any of the study medications

          9. Known history of alcohol (&gt; 2 drinks per day) or drug abuse Active (in the past year)
             history of alcohol abuse (â¥5 drinks/day for men or â¥4 drinks/day for women) as
             determined by reviewing medical record and history given by the patient

         10. Liver dysfunction (liver enzymes &gt; 4 times the baseline, all patients will have a
             baseline liver function test evaluation), history and examination suggestive of
             jaundice.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Balachundhar Subramaniam, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med. 2010 Dec 30;363(27):2638-50. doi: 10.1056/NEJMra0808281. Review.</citation>
    <PMID>21190458</PMID>
  </reference>
  <reference>
    <citation>Brown EN, Pavone KJ, Naranjo M. Multimodal General Anesthesia: Theory and Practice. Anesth Analg. 2018 Nov;127(5):1246-1258. doi: 10.1213/ANE.0000000000003668. Review.</citation>
    <PMID>30252709</PMID>
  </reference>
  <reference>
    <citation>McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, Lau J, Carr D; Americal Pain Society. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003 Jun;4(5):231-56. Review.</citation>
    <PMID>14622694</PMID>
  </reference>
  <reference>
    <citation>Volkow ND, Collins FS. The Role of Science in the Opioid Crisis. N Engl J Med. 2017 Nov 2;377(18):1798. doi: 10.1056/NEJMc1711494.</citation>
    <PMID>29117474</PMID>
  </reference>
  <reference>
    <citation>Mulier J. Opioid free general anesthesia: A paradigm shift? Rev Esp Anestesiol Reanim. 2017 Oct;64(8):427-430. doi: 10.1016/j.redar.2017.03.004. Epub 2017 Apr 18. English, Spanish.</citation>
    <PMID>28431750</PMID>
  </reference>
  <reference>
    <citation>MacKenzie KK, Britt-Spells AM, Sands LP, Leung JM. Processed Electroencephalogram Monitoring and Postoperative Delirium: A Systematic Review and Meta-analysis. Anesthesiology. 2018 Sep;129(3):417-427. doi: 10.1097/ALN.0000000000002323.</citation>
    <PMID>29912008</PMID>
  </reference>
  <reference>
    <citation>Depth of anaesthesia monitors - Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M | Guidance and guidelines | NICE [Internet]. [cited 2018 Dec 24];Available from: https://www.nice.org.uk/guidance/dg6</citation>
  </reference>
  <reference>
    <citation>Wildes TS, Mickle AM, Ben Abdallah A, Maybrier HR, Oberhaus J, Budelier TP, Kronzer A, McKinnon SL, Park D, Torres BA, Graetz TJ, Emmert DA, Palanca BJ, Goswami S, Jordan K, Lin N, Fritz BA, Stevens TW, Jacobsohn E, Schmitt EM, Inouye SK, Stark S, Lenze EJ, Avidan MS; ENGAGES Research Group. Effect of Electroencephalography-Guided Anesthetic Administration on Postoperative Delirium Among Older Adults Undergoing Major Surgery: The ENGAGES Randomized Clinical Trial. JAMA. 2019 Feb 5;321(5):473-483. doi: 10.1001/jama.2018.22005.</citation>
    <PMID>30721296</PMID>
  </reference>
  <reference>
    <citation>Wilson PT, Spitzer RL. Major changes in psychiatric nomenclature. Reconciling existing psychiatric medical records with the new American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. Hosp Community Psychiatry. 1968 Jun;19(6):169-74.</citation>
    <PMID>5661463</PMID>
  </reference>
  <reference>
    <citation>SauÃ«r AM, Slooter AJ, Veldhuijzen DS, van Eijk MM, Devlin JW, van Dijk D. Intraoperative dexamethasone and delirium after cardiac surgery: a randomized clinical trial. Anesth Analg. 2014 Nov;119(5):1046-52. doi: 10.1213/ANE.0000000000000248.</citation>
    <PMID>24810262</PMID>
  </reference>
  <reference>
    <citation>Rudolph JL, Jones RN, Levkoff SE, Rockett C, Inouye SK, Sellke FW, Khuri SF, Lipsitz LA, Ramlawi B, Levitsky S, Marcantonio ER. Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation. 2009 Jan 20;119(2):229-36. doi: 10.1161/CIRCULATIONAHA.108.795260. Epub 2008 Dec 31.</citation>
    <PMID>19118253</PMID>
  </reference>
  <reference>
    <citation>Burkhart CS, Dell-Kuster S, Gamberini M, Moeckli A, Grapow M, Filipovic M, Seeberger MD, Monsch AU, Strebel SP, Steiner LA. Modifiable and nonmodifiable risk factors for postoperative delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2010 Aug;24(4):555-9. doi: 10.1053/j.jvca.2010.01.003. Epub 2010 Mar 15.</citation>
    <PMID>20227891</PMID>
  </reference>
  <reference>
    <citation>Arora RC, Djaiani G, Rudolph JL. Detection, Prevention, and Management of Delirium in the Critically Ill Cardiac Patient and Patients Who Undergo Cardiac Procedures. Can J Cardiol. 2017 Jan;33(1):80-87. doi: 10.1016/j.cjca.2016.08.020. Epub 2016 Oct 5. Review.</citation>
    <PMID>28024558</PMID>
  </reference>
  <reference>
    <citation>Delirium: prevention, diagnosis and management | Guidance and guidelines | NICE [Internet]. [cited 2018 Dec 20];Available from: https://www.nice.org.uk/guidance/cg103</citation>
  </reference>
  <reference>
    <citation>Pesonen A, Suojaranta-Ylinen R, HammarÃ©n E, Kontinen VK, Raivio P, Tarkkila P, Rosenberg PH. Pregabalin has an opioid-sparing effect in elderly patients after cardiac surgery: a randomized placebo-controlled trial. Br J Anaesth. 2011 Jun;106(6):873-81. doi: 10.1093/bja/aer083. Epub 2011 Apr 6.</citation>
    <PMID>21474474</PMID>
  </reference>
  <reference>
    <citation>Urban MK, Ya Deau JT, Wukovits B, Lipnitsky JY. Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. HSS J. 2008 Feb;4(1):62-5. doi: 10.1007/s11420-007-9069-9. Epub 2007 Dec 19.</citation>
    <PMID>18751864</PMID>
  </reference>
  <reference>
    <citation>Ballard C, Jones E, Gauge N, Aarsland D, Nilsen OB, Saxby BK, Lowery D, Corbett A, Wesnes K, Katsaiti E, Arden J, Amoako D, Prophet N, Purushothaman B, Green D. Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One. 2012;7(6):e37410. doi: 10.1371/journal.pone.0037410. Epub 2012 Jun 15. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/1cc38e55-23e8-44a5-ac2b-43c7b2a880f9. Amaoko, Derek [corrected to Amoako, Derek]. PLoS One. 2013;8(9). doi:10.1371/annotation/c0569644-bea1-4c38-af9a-75d1168e3142.</citation>
    <PMID>22719840</PMID>
  </reference>
  <reference>
    <citation>Chan MT, Cheng BC, Lee TM, Gin T; CODA Trial Group. BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J Neurosurg Anesthesiol. 2013 Jan;25(1):33-42. doi: 10.1097/ANA.0b013e3182712fba.</citation>
    <PMID>23027226</PMID>
  </reference>
  <reference>
    <citation>Stoppe C, Fahlenkamp AV, Rex S, Veeck NC, Gozdowsky SC, SchÃ¤lte G, Autschbach R, Rossaint R, Coburn M. Feasibility and safety of xenon compared with sevoflurane anaesthesia in coronary surgical patients: a randomized controlled pilot study. Br J Anaesth. 2013 Sep;111(3):406-16. doi: 10.1093/bja/aet072. Epub 2013 Apr 11.</citation>
    <PMID>23578862</PMID>
  </reference>
  <reference>
    <citation>Lurati Buse GA, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J, Kasper J, Filipovic M, Bolliger D, Seeberger MD. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation. 2012 Dec 4;126(23):2696-704. doi: 10.1161/CIRCULATIONAHA.112.126144. Epub 2012 Nov 7.</citation>
    <PMID>23136158</PMID>
  </reference>
  <reference>
    <citation>Papaioannou A, Fraidakis O, Michaloudis D, Balalis C, Askitopoulou H. The impact of the type of anaesthesia on cognitive status and delirium during the first postoperative days in elderly patients. Eur J Anaesthesiol. 2005 Jul;22(7):492-9.</citation>
    <PMID>16045136</PMID>
  </reference>
  <reference>
    <citation>Jia Y, Jin G, Guo S, Gu B, Jin Z, Gao X, Li Z. Fast-track surgery decreases the incidence of postoperative delirium and other complications in elderly patients with colorectal carcinoma. Langenbecks Arch Surg. 2014 Jan;399(1):77-84. doi: 10.1007/s00423-013-1151-9. Epub 2013 Dec 13.</citation>
    <PMID>24337734</PMID>
  </reference>
  <reference>
    <citation>Purdon PL, Sampson A, Pavone KJ, Brown EN. Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures. Anesthesiology. 2015 Oct;123(4):937-60. doi: 10.1097/ALN.0000000000000841. Review.</citation>
    <PMID>26275092</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 9, 2019</study_first_submitted>
  <study_first_submitted_qc>July 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2019</study_first_posted>
  <last_update_submitted>May 4, 2020</last_update_submitted>
  <last_update_submitted_qc>May 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiopulmonary Bypass</keyword>
  <keyword>Cardiac Surgery</keyword>
  <keyword>analgesics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

